Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
|
|
493 * !
|
Wed, 8/2/2017,
10:30 AM -
12:20 PM
|
CC-329
|
Bayesian Model-Based and Rule-Based Dose Escalation Designs in Oncology — Topic Contributed Papers
|
Section on Bayesian Statistical Science , Biopharmaceutical Section
|
Organizer(s): Charles Liu, Cytel Inc.
|
Chair(s): Erik Pulkstenis, Medimmune
|
10:35 AM
|
A Case Study Exploration of MTPI and Proposed Methods to Expand to Combination Drug Development
—
Matthew Gribbin, MedImmune ; Nairouz Elgeioushi, MedImmune
|
10:55 AM
|
Alternative Dose Escalation Rules for Dual Agent Designs
—
Charles Liu, Cytel Inc. ; Yannis Jemiai, Cytel Inc. ; Sam Hsiao, Cytel, Inc ; Hrishikesh Kulkarni, Cytel Inc.
|
11:15 AM
|
Combination Dose Finding in Phase I Oncology Trials: a Co-Data Approach
—
Niladri Roy Chowdhury, Novartis Oncology Pharmaceuticals ; Satrajit Roychoudhury, Pfizer Inc
|
11:35 AM
|
Model-based Design for the Early Development of Cancer Immunotherapy Combinations
—
Nolan Wages, University of Virgina
|
11:55 AM
|
Discussant: Guan Xing, Gilead
|
12:15 PM
|
Floor Discussion
|
|